Lawrence C Layman1, David P Cohen, Jun Xie, Gary D Smith. 1. and Genetics, Department of Obstetrics and Gynecology, Neurobiology Program, The Institute of Molecular Medicine and Genetics, The Medical College of Georgia., Augusta, Georgia 30912-3360, USA. llayman@mail.mcg.edu
Abstract
OBJECTIVE: To characterize the genotype and phenotype of a man with idiopathic hypogonadism with infertility. DESIGN: Molecular analysis and clinical description. SETTING: Medical school laboratory and reproductive endocrine clinic.A 40-year-old male with idiopathic hypogonadotropic hypogonadism. INTERVENTION(S): Denaturing gradient gel electrophoresis analysis and DNA sequencing of the gonadotropin-releasing hormone receptor (GNRHR) gene were performed. The patient was treated with hCG and FSH. MAIN OUTCOME MEASURE(S): GNRHR mutation detection, genotype/phenotype correlation, and testicular response to exogenous gonadotropin therapy. RESULT(S): The proband demonstrated compound heterozygosity for Ala129Asp/Arg262Gln GNRHR mutations. He had a complete form of idiopathic hypogonadotropic hypogonadism, with descended testes and severe oligospermia but little response to exogenous gonadotropins. CONCLUSION(S): The phenotype of this patient differs from the one other family described with the same mutations. Exogenous gonadotropin therapy may not be as beneficial for increasing sperm concentration in older men with idiopathic hypogonadotropic hypogonadism.
OBJECTIVE: To characterize the genotype and phenotype of a man with idiopathic hypogonadism with infertility. DESIGN: Molecular analysis and clinical description. SETTING: Medical school laboratory and reproductive endocrine clinic.A 40-year-old male with idiopathic hypogonadotropic hypogonadism. INTERVENTION(S): Denaturing gradient gel electrophoresis analysis and DNA sequencing of the gonadotropin-releasing hormone receptor (GNRHR) gene were performed. The patient was treated with hCG and FSH. MAIN OUTCOME MEASURE(S): GNRHR mutation detection, genotype/phenotype correlation, and testicular response to exogenous gonadotropin therapy. RESULT(S): The proband demonstrated compound heterozygosity for Ala129Asp/Arg262Gln GNRHR mutations. He had a complete form of idiopathic hypogonadotropic hypogonadism, with descended testes and severe oligospermia but little response to exogenous gonadotropins. CONCLUSION(S): The phenotype of this patient differs from the one other family described with the same mutations. Exogenous gonadotropin therapy may not be as beneficial for increasing sperm concentration in older men with idiopathic hypogonadotropic hypogonadism.
Authors: Hyung-Goo Kim; Jennifer Pedersen-White; Balasubramanian Bhagavath; Lawrence C Layman Journal: Front Horm Res Date: 2010-04-08 Impact factor: 2.606
Authors: Lin Lin; Gerard S Conway; Nathan R Hill; Mehul T Dattani; Peter C Hindmarsh; John C Achermann Journal: J Clin Endocrinol Metab Date: 2006-09-12 Impact factor: 5.958